Facing diminishing resources, climate change, and hungrier populations, agriculture is trying new tools such as POC testing, microbiome management, and post-GMO crop development.
As Corvidia CEO, Marc de Garidel saw the heart disease biotech through a $2.1 billion acquisition by Novo Nordisk. Barely two months later, he’s back in the saddle, this time at ...
Bob Duggan could easily have called it a career in 2015, after he sold Pharma- cyclics, his cancer-drug biotech, to AbbVie.
The world is seeing an unprecedented response to the pandemic by biotechnology researchers, emerging companies, and a wide range of pharmaceuticals. The results and the pace of innovation ...
The $200 million investment in CStone Pharmaceuticals puts Pfizer in charge of selling a cancer immunotherapy in the world's second largest drug market.
For today's Building Better, we spoke with Bill Baumel, Managing Director at Ohio Innovation Fund (OIF), and with Amanda Epp, CEO of ScriptDrop, an OIF portfolio company. Learn about their ...
Manifold, the applied AI company, announced seed financing to support continued rapid growth of its AI foundry.